Genetic Mosaic Analysis Reveals FGF Receptor 2 Function in Terminal End Buds During Mammary Gland Branching Morphogenesis

Overview

Journal Dev Biol

Publisher Elsevier

Specialties Biology
Reproductive Medicine

Date 2008 Jul 1

PMID 18585375

Citations 112

Authors

Pengfei Lu

Andrew J Ewald

Gail R Martin

Zena Werb

Affiliations

Soon will be listed here.

Abstract

FGF signaling is associated with breast cancer and is required for mammary placode formation in the mouse. In this study, we employed a genetic mosaic analysis based on Cre-mediated recombination to investigate FGF receptor 2 (Fgfr2) function in the postnatal mammary gland. Mosaic inactivation of Fgfr2 by the MMTV-Cre transgene enabled us to compare the behavior of Fgfr2 null and Fgfr2 heterozygous cells in the same gland. Fgfr2 null cells were at a competitive disadvantage to their Fgfr2 heterozygous neighbors in the highly proliferative terminal end buds (TEBs) at the invasion front, owing to a negative effect of loss of Fgfr2 function on cell proliferation. However, Fgfr2 null cells were tolerated in mature ducts. In these genetic mosaic mammary glands, the epithelial network is apparently built by TEBs that over time are composed of a progressively larger proportion of Fgfr2-positive cells. However, subsequently, most cells lose Fgfr2 function, presumably due to additional rounds of Cre-mediated recombination. Using an independent strategy to create mosaic mammary glands, which employed an adenovirus-Cre that acts only once, we confirmed that Fgfr2 null cells were out-competed by neighboring Fgfr2 heterozygous cells. Together, our data demonstrate that Fgfr2 functions in the proliferating and invading TEBs, but it is not required in the mature ducts of the pubertal mammary gland.

Citing Articles

Hormone Signaling in Breast Development and Cancer.

Agnoletto A, Brisken C Adv Exp Med Biol. 2025; 1464():279-307.

PMID: 39821031 DOI: 10.1007/978-3-031-70875-6_15.

Different Biomechanical Cell Behaviors in an Epithelium Drive Collective Epithelial Cell Extrusion.

Balasubramaniam L, Jain S, Dang T, Lagoutte E, Marc Mege R, Chavrier P Adv Sci (Weinh). 2024; 11(42):e2401573.

PMID: 39291385 PMC: 11558136. DOI: 10.1002/advs.202401573.

Targeting Tumor Heterogeneity by Breaking a Stem Cell and Epithelial Niche Interaction Loop.

Ma R, Feng D, Chen J, Zhou J, Xia K, Kong X Adv Sci (Weinh). 2024; 11(26):e2307452.

PMID: 38708713 PMC: 11234407. DOI: 10.1002/advs.202307452.

Sprouty genes regulate activated fibroblasts in mammary epithelial development and breast cancer.

Li J, Ma R, Wang X, Lu Y, Chen J, Feng D Cell Death Dis. 2024; 15(4):256.

PMID: 38600092 PMC: 11006910. DOI: 10.1038/s41419-024-06637-2.

Diverse roles for axon guidance pathways in adult tissue architecture and function.

Laws K, Bashaw G Nat Sci (Weinh). 2023; 2(4).

PMID: 37456985 PMC: 10346896. DOI: 10.1002/ntls.20220021.

References

Parsa S, Ramasamy S, De Langhe S, Gupte V, Haigh J, Medina D . Terminal end bud maintenance in mammary gland is dependent upon FGFR2b signaling. Dev Biol. 2008; 317(1):121-31. DOI: 10.1016/j.ydbio.2008.02.014. View

Joseph H, Gorska A, Sohn P, Moses H, Serra R . Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching. Mol Biol Cell. 1999; 10(4):1221-34. PMC: 25256. DOI: 10.1091/mbc.10.4.1221. View

Tam P, Rossant J . Mouse embryonic chimeras: tools for studying mammalian development. Development. 2003; 130(25):6155-63. DOI: 10.1242/dev.00893. View

Coumoul X, Deng C . Roles of FGF receptors in mammalian development and congenital diseases. Birth Defects Res C Embryo Today. 2004; 69(4):286-304. DOI: 10.1002/bdrc.10025. View

Lu P, Yu Y, Perdue Y, Werb Z . The apical ectodermal ridge is a timer for generating distal limb progenitors. Development. 2008; 135(8):1395-405. PMC: 2574509. DOI: 10.1242/dev.018945. View

Mailleux A, Overholtzer M, Schmelzle T, Bouillet P, Strasser A, Brugge J . BIM regulates apoptosis during mammary ductal morphogenesis, and its absence reveals alternative cell death mechanisms. Dev Cell. 2007; 12(2):221-34. PMC: 2698712. DOI: 10.1016/j.devcel.2006.12.003. View

Xu X, Weinstein M, Li C, Naski M, Cohen R, Ornitz D . Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. Development. 1998; 125(4):753-65. DOI: 10.1242/dev.125.4.753. View

Affolter M, Bellusci S, Itoh N, Shilo B, Thiery J, Werb Z . Tube or not tube: remodeling epithelial tissues by branching morphogenesis. Dev Cell. 2003; 4(1):11-8. DOI: 10.1016/s1534-5807(02)00410-0. View

Bonnette S, Hadsell D . Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds. Endocrinology. 2001; 142(11):4937-45. DOI: 10.1210/endo.142.11.8500. View

10.

Lebeche D, Malpel S, Cardoso W . Fibroblast growth factor interactions in the developing lung. Mech Dev. 1999; 86(1-2):125-36. DOI: 10.1016/s0925-4773(99)00124-0. View

11.

Mailleux A, Spencer-Dene B, Dillon C, Ndiaye D, Savona-Baron C, Itoh N . Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo. Development. 2002; 129(1):53-60. DOI: 10.1242/dev.129.1.53. View

12.

Itoh N, Ornitz D . Evolution of the Fgf and Fgfr gene families. Trends Genet. 2004; 20(11):563-9. DOI: 10.1016/j.tig.2004.08.007. View

13.

Cheng N, Bhowmick N, Chytil A, Gorksa A, Brown K, Muraoka R . Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. Oncogene. 2005; 24(32):5053-68. PMC: 3074577. DOI: 10.1038/sj.onc.1208685. View

14.

Stark K, McMahon J, McMahon A . FGFR-4, a new member of the fibroblast growth factor receptor family, expressed in the definitive endoderm and skeletal muscle lineages of the mouse. Development. 1991; 113(2):641-51. DOI: 10.1242/dev.113.2.641. View

15.

Poladia D, Kish K, Kutay B, Hains D, Kegg H, Zhao H . Role of fibroblast growth factor receptors 1 and 2 in the metanephric mesenchyme. Dev Biol. 2006; 291(2):325-39. DOI: 10.1016/j.ydbio.2005.12.034. View

16.

Rohlmann A, Gotthardt M, Willnow T, Hammer R, Herz J . Sustained somatic gene inactivation by viral transfer of Cre recombinase. Nat Biotechnol. 1996; 14(11):1562-5. DOI: 10.1038/nbt1196-1562. View

17.

Lewis M, Ross S, Strickland P, Sugnet C, Jimenez E, Scott M . Defects in mouse mammary gland development caused by conditional haploinsufficiency of Patched-1. Development. 1999; 126(22):5181-93. DOI: 10.1242/dev.126.22.5181. View

18.

Seagroves T, Hadsell D, McManaman J, Palmer C, Liao D, McNulty W . HIF1alpha is a critical regulator of secretory differentiation and activation, but not vascular expansion, in the mouse mammary gland. Development. 2003; 130(8):1713-24. DOI: 10.1242/dev.00403. View

19.

Jackson D, Bresnick J, Rosewell I, Crafton T, Poulsom R, Stamp G . Fibroblast growth factor receptor signalling has a role in lobuloalveolar development of the mammary gland. J Cell Sci. 1997; 110 ( Pt 11):1261-8. DOI: 10.1242/jcs.110.11.1261. View

20.

Uv A, Cantera R, Samakovlis C . Drosophila tracheal morphogenesis: intricate cellular solutions to basic plumbing problems. Trends Cell Biol. 2003; 13(6):301-9. DOI: 10.1016/s0962-8924(03)00083-7. View